Diazacarbazoles and methods of use
US8501765B2 · kind B2 · utility
2Cited by
0References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 2009 |
| Grant date | Aug 6, 2013 |
| Priority date | — |
| Expiry date | Apr 18, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to 1,7-diazacarbazole compounds of Formula (I), which are useful as kinase inhibitors, more specifically useful as checkpoint kinase I (chk1) inhibitors, thus useful as cancer therapeutics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.